3- .
Weissferdt A, Leung CH, Lin H, Sepesi B, William WN, Swisher SG , Cascone T, Lee JJ, Pataer A
Lipo-B injections may then accelerate the fat-burning within that framework
Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono
Now that the MHRA has granted licensing, NICE will assess whether they're cost-effective for NHS use
Tester feedback from senior news editor Nicola DallAsen When my skin's in serious need of extra TLCas in, spend-an-entire-night-doing-a-12-step-routine seriousthis serum is the first thing I grab after my face is double-cleansed